Literature DB >> 28847165

Advanced nanomedicine for rheumatoid arthritis treatment: focus on active targeting.

Minglei Chen1, Kambere Amerigos Daddy J C1, Yanyu Xiao1, Qineng Ping1, Li Zong1.   

Abstract

Entities:  

Keywords:  Rheumatoid arthritis; active targeting; nanomedicine; treatment

Year:  2017        PMID： 28847165     DOI： 10.1080/17425247.2017.1372746

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN： 1742-5247            Impact factor:   6.648


× No keyword cloud information.
  6 in total

1.  PLGA Nanoparticles Grafted with Hyaluronic Acid to Improve Site-Specificity and Drug Dose Delivery in Osteoarthritis Nanotherapy.

Authors:  Luana Zerrillo; Maria Rosa Gigliobianco; Domenico D'Atri; Joao Pedro Garcia; Fabio Baldazzi; Yanto Ridwan; Gastón Fuentes; Alan Chan; Laura B Creemers; Roberta Censi; Piera Di Martino; Luis J Cruz
Journal:  Nanomaterials (Basel)       Date:  2022-06-30       Impact factor: 5.719

Review 2.  Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery.

Authors:  Okhil K Nag; James B Delehanty
Journal:  Pharmaceutics       Date:  2019-10-18       Impact factor: 6.321

3.  Delivery of germacrone (GER) using macrophages-targeted polymeric nanoparticles and its application in rheumatoid arthritis.

Authors:  Tingfei Tan; Qi Huang; Weiwei Chu; Bo Li; Jingjing Wu; Quan Xia; Xi Cao
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 4.  Role of CD47-SIRPα Checkpoint in Nanomedicine-Based Anti-Cancer Treatment.

Authors:  Haiqin Liao; Chengcheng Niu
Journal:  Front Bioeng Biotechnol       Date:  2022-04-26

Review 5.  Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies.

Authors:  Qin Wang; Xianyan Qin; Jiyu Fang; Xun Sun
Journal:  Acta Pharm Sin B       Date:  2021-03-12       Impact factor: 11.413

6.  Ceria-based nanotheranostic agent for rheumatoid arthritis.

Authors:  Irina Kalashnikova; Seock-Jin Chung; Md Nafiujjaman; Meghan L Hill; Mzingaye E Siziba; Christopher H Contag; Taeho Kim
Journal:  Theranostics       Date:  2020-10-25       Impact factor: 11.556
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.